Coagulation laboratory tests
Prothrombin gene 20210A testing
Reviewer: Jeremy Parsons, M.D. (see Reviewers page)
Revised: 10 February 2013, last major update November 2012
Copyright: (c) 2002-2013, PathologyOutlines.com, Inc.
● Mutation in G to A transition at nucleotide 20210 in 3’ untranslated portion of prothrombin gene, which introduces a new Hind III restriction site
● Can identify heterozygotes and homozygotes
● G20210A mutation in heterozygotes is associated with increased risk of first venous thromboembolic episode (Br J Haematol 2001;113:630)
● Multiplexed arrays test for factor V Leiden, MTHFR C677T and other sequences
● Specimen is whole blood
● Usually PCR amplification of 3’ untranslated region of prothrombin gene surrounding the 20210 polymorphism, then either gel electrophoresis, radioisotopic probing or restriction endonuclease digestion with Hind III to detect the nucleotide sequence
End of Coagulation > Coagulation laboratory tests > Prothrombin gene 20210A testing
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).